Related Experiment Video
Updated: Aug 17, 2026
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Venous thrombosis in inflammatory bowel disease
Rajaventhan Srirajaskanthan1, Mark Winter, Andrew F Muller
1Department of Gastroenterology, the Kent and Canterbury Hospital, Canterbury, Kent CT1 3NG, UK.
Insights
Patients with inflammatory bowel disease (IBD) face a threefold higher risk of venous thrombosis. Research explores multifactorial causes, including coagulation, fibrinolysis, and platelet activation, to understand this increased risk.
Area of Science:
- Gastroenterology
- Hematology
- Vascular Medicine
Background:
- Inflammatory bowel disease (IBD) significantly elevates venous thrombosis risk (3x).
- Thrombosis in IBD patients is a critical factor in morbidity and mortality.
- The precise mechanisms initiating thrombosis in IBD remain incompletely understood.
Purpose of the Study:
- To review the multifactorial processes contributing to thrombosis in IBD.
- To discuss the role of thrombophilic disorders in IBD-associated thrombosis.
- To examine recent findings on elevated CD40, P-selectin, and microvesicles in venous thrombosis and their relevance to IBD.
Main Methods:
- Literature review of studies on IBD and venous thrombosis.
- Analysis of reported abnormalities in coagulation cascade markers.
- Examination of platelet activation and fibrinolysis disturbances.
Main Results:
- Abnormalities in coagulation, fibrinolysis, and platelet activation are implicated.
- The contribution of specific thrombophilic disorders (Factor V Leiden, prothrombin gene mutations, hyperhomocysteinemia) to IBD thrombosis is unclear.
- Elevated CD40, P-selectin, and tissue factor-bearing microvesicles are recent findings in venous thrombosis.
Conclusions:
- Thrombosis in IBD is a complex, multifactorial event.
- Further research is needed to clarify the role of specific thrombophilic factors and novel markers in IBD-associated venous thrombosis.
Abstract:
Patients with inflammatory bowel disease (IBD) have a threefold increased risk of venous thrombosis, a major cause of morbidity and mortality. Although the exact mechanism explaining the initiation of thrombosis remains unclear, it is likely to be a multifactorial process. Reported abnormalities include activation of markers of the coagulation cascade, disturbed fibrinolysis and the activation of platelets. The contribution of thrombophilic disorders such as factor V Leiden, prothrombin gene mutations and hyperhomocysteinaemia are discussed, but their role in thrombosis associated with IBD has remained unclear. Recent research has examined elevated CD40, P-selectin levels and tissue factor-bearing microvesicles in venous thrombosis, and the relevance of these observations to IBD is reviewed.
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:26Inflammatory Bowel Disease I: Introduction
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...